Indeed, many studies over the past years, including studies in patients with diabetic nephropathy, have shown that FGF23 levels are increased in CKD patients, most likely in response to a reduced renal capacity to excrete phosphate. The gene discussed is FGF23; the disease is diabetic kidney disease.